Related references
Note: Only part of the references are listed.Comparative genomic analysis of head and body/tail of pancreatic ductal adenocarcinoma at early and late stages
Xueyou Zhang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
Genetic aberrations in Chinese pancreatic cancer patients and their association with anatomic location and disease outcomes
Junliang Lu et al.
CANCER MEDICINE (2021)
Distinct genomic profile in h. pylori-associated gastric cancer
Xiaochen Zhang et al.
CANCER MEDICINE (2021)
The germline/somatic DNA damage repair gene mutations modulate the therapeutic response in Chinese patients with advanced pancreatic ductal adenocarcinoma
Lin Shui et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2021)
Evidence of NTRK1 Fusion as Resistance Mechanism to EGFR TKI in EGFR plus NSCLC: Results From a Large-Scale Survey of NTRK1 Fusions in Chinese Patients With Lung Cancer
Hui Xia et al.
CLINICAL LUNG CANCER (2020)
Atypical KRASG12R Mutant Is Impaired in PI3K Signaling and Macropinocytosis in Pancreatic Cancer
G. Aaron Hobbs et al.
CANCER DISCOVERY (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Pattern of Invasion in Human Pancreatic Cancer Organoids Is Associated with Loss of SMAD4 and Clinical Outcome
Wenjie Huang et al.
CANCER RESEARCH (2020)
TP53 Mutations Predict Sensitivity to Adjuvant Gemcitabine in Patients with Pancreatic Ductal Adenocarcinoma: Next-Generation Sequencing Results from the CONKO-001 Trial
Marianne Sinn et al.
CLINICAL CANCER RESEARCH (2020)
Frequency of mismatch repair deficiency in pancreatic ductal adenocarcinoma
Soz Abdulrahman Ahmad-Nielsen et al.
PATHOLOGY RESEARCH AND PRACTICE (2020)
The Role of Location of Tumor in the Prognosis of the Pancreatic Cancer
Mirang Lee et al.
CANCERS (2020)
Molecular characterization of organoids derived from pancreatic intraductal papillary mucinous neoplasms
Bo Huang et al.
JOURNAL OF PATHOLOGY (2020)
The genomic features of Chinese pancreatic adenocarcinoma and the implications for therapy
W. Wang et al.
ANNALS OF ONCOLOGY (2020)
Comprehensive molecular profiling of pancreatic ductal adenocarcinoma in Chinese population
R. Liu et al.
ANNALS OF ONCOLOGY (2020)
Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers
Aatur D. Singhi et al.
GASTROENTEROLOGY (2019)
Pancreatic ductal adenocarcinoma harboring microsatellite instability / DNA mismatch repair deficiency. Towards personalized medicine
Renato M. Lupinacci et al.
SURGICAL ONCOLOGY-OXFORD (2019)
Phase 1 study evaluating the safety, tolerability, pharmacokinetics (PK), and efficacy of AMG 510, a novel small molecule KRASG12c inhibitor, in advanced solid tumors.
Marwan Fakih et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
A phase I/II multiple expansion cohort trial of MRTX849 in patients with advanced solid tumors with KRAS G12C mutation.
Kyriakos P. Papadopoulos et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Head and Body/Tail Pancreatic Carcinomas Are Not the Same Tumors
David Jeremie Birnbaum et al.
CANCERS (2019)
Genes associated with increased brain metastasis risk in non-small cell lung cancer: Comprehensive genomic profiling of 61 resected brain metastases versus primary non-small cell lung cancer (Guangdong Association Study of Thoracic Oncology 1036)
Hongsheng Wang et al.
CANCER (2019)
Dual Farnesyl and Geranylgeranyl Transferase Inhibitor Thwarts Mutant KRAS-Driven Patient-Derived Pancreatic Tumors
Aslamuzzaman Kazi et al.
CLINICAL CANCER RESEARCH (2019)
The Impact of Tumor Location on Resection and Survival for Pancreatic Ductal Adenocarcinoma
Leah K. Winer et al.
JOURNAL OF SURGICAL RESEARCH (2019)
Genomic Landscape of Pancreatic Adenocarcinoma in Younger versus Older Patients: Does Age Matter?
Irit Ben-Aharon et al.
CLINICAL CANCER RESEARCH (2019)
Pathology of pancreatic cancer
Lena Haeberle et al.
TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Defining the molecular pathology of pancreatic body and tail adenocarcinoma
S. B. Dreyer et al.
BRITISH JOURNAL OF SURGERY (2018)
Evaluating Mismatch Repair Deficiency in Pancreatic Adenocarcinoma: Challenges and Recommendations
Zishuo I. Hu et al.
CLINICAL CANCER RESEARCH (2018)
IPMNs with co-occurring invasive cancers: neighbours but not always relatives
Matthaus Felsenstein et al.
GUT (2018)
SMAD4 promotes TGF-β-independent NK cell homeostasis and maturation and antitumor immunity
Youwei Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Hypermutation In Pancreatic Cancer
Jeremy L. Humphris et al.
GASTROENTEROLOGY (2017)
Fusions in solid tumours: diagnostic strategies, targeted therapy, and acquired resistance
Alison M. Schram et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Postoperative serum CEA and CA125 levels are supplementary to perioperative CA19-9 levels in predicting operative outcomes of pancreatic ductal adenocarcinoma
Hua-Xiang Xu et al.
SURGERY (2017)
Diagnostic Accuracy of a CA125-Based Biomarker Panel in Patients with Pancreatic Cancer: A Systematic Review and Meta-Analysis
Qingcai Meng et al.
JOURNAL OF CANCER (2017)
KrasG12D induces EGFR-MYC cross signaling in murine primary pancreatic ductal epithelial cells
S. Diersch et al.
ONCOGENE (2016)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Activation Mechanism of Oncogenic Deletion Mutations in BRAF, EGFR, and HER2
Scott A. Foster et al.
CANCER CELL (2016)
Genomic analyses identify molecular subtypes of pancreatic cancer
Peter Bailey et al.
NATURE (2016)
Prognostic impact of preoperative NLR and CA19-9 in pancreatic cancer
Tadafumi Asaoka et al.
PANCREATOLOGY (2016)
Pancreatic cancer biology and genetics from an evolutionary perspective
Alvin Makohon-Moore et al.
NATURE REVIEWS CANCER (2016)
Whole genomes redefine the mutational landscape of pancreatic cancer
Nicola Waddell et al.
NATURE (2015)
Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets
Agnieszka K. Witkiewicz et al.
NATURE COMMUNICATIONS (2015)
A preoperative serum signature of CEA+/CA125+/CA19-9 ≥ 1000 U/mL indicates poor outcome to pancreatectomy for pancreatic cancer
Liang Liu et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
FACTERA: a practical method for the discovery of genomic rearrangements at breakpoint resolution
Aaron M. Newman et al.
BIOINFORMATICS (2014)
Locally Advanced Pancreatic Cancer Association Between Prolonged Preoperative Treatment and Lymph-Node Negativity and Overall Survival
Brian E. Kadera et al.
JAMA SURGERY (2014)
CA19-9 in Potentially Resectable Pancreatic Cancer: Perspective to Adjust Surgical and Perioperative Therapy
Werner Hartwig et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Prognostic value of K-ras mutation status and subtypes in endoscopic ultrasound-guided fine-needle aspiration specimens from patients with unresectable pancreatic cancer
Takeshi Ogura et al.
JOURNAL OF GASTROENTEROLOGY (2013)
Reversing Effect of Ring Finger Protein 43 Inhibition on Malignant Phenotypes of human Hepatocellular Carcinoma
Chunyang Xing et al.
MOLECULAR CANCER THERAPEUTICS (2013)
DELLY: structural variant discovery by integrated paired-end and split-read analysis
Tobias Rausch et al.
BIOINFORMATICS (2012)
VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing
Daniel C. Koboldt et al.
GENOME RESEARCH (2012)
Multiple oligomerization domains of KANK1-PDGFRβ are required for JAK2-independent hematopoietic cell proliferation and signaling via STAT5 and ERK
Sandrine Medves et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression
Zhihu Ding et al.
NATURE (2011)
Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
Eric A. Collisson et al.
NATURE MEDICINE (2011)
Recurrent GNAS Mutations Define an Unexpected Pathway for Pancreatic Cyst Development
Jian Wu et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Fast and accurate long-read alignment with Burrows-Wheeler transform
Heng Li et al.
BIOINFORMATICS (2010)
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
Aaron McKenna et al.
GENOME RESEARCH (2010)
Incidence and Survival of Pancreatic Head and Body and Tail Cancers A Population-Based Study in the United States
Melvin K. Lau et al.
PANCREAS (2010)
SMAD4 Gene Mutations Are Associated with Poor Prognosis in Pancreatic Cancer
Amanda Blackford et al.
CLINICAL CANCER RESEARCH (2009)
The anatomic location of pancreatic cancer is a prognostic factor for survival
Avo Artinyan et al.
HPB (2008)
X-tile: A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization
RL Camp et al.
CLINICAL CANCER RESEARCH (2004)
Smad-dependent and Smad-independent pathways in TGF-β family signalling
R Derynck et al.
NATURE (2003)
Almost all infiltrating colloid carcinomas of the pancreas and periampullary region arise from in situ papillary neoplasms - A study of 39 cases
G Seidel et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2002)
Share Paper
